Insitro

Insitro is a data-driven drug discovery and development company based in South San Francisco, California. The company employs 322 individuals and has generated $100 million in revenue. Insitro focuses on transforming the way medicines are created to benefit patients by utilizing machine learning and high-throughput biology. Insitro's approach involves rethinking the entire drug discovery process from the ground up, incorporating machine learning, human genetics, and high-throughput quantitative biology. They develop in vitro human cell-derived disease models designed to predict human clinical outcomes, aiming to accelerate and reduce the cost of drug development. This ultimately aims to help more patients access treatments sooner. The company invests heavily in cutting-edge bioengineering technologies to create large-scale, high-quality datasets specifically tailored to drive machine learning methods. Insitro fosters a unique culture that brings together experts from diverse fields, including life sciences, machine learning, human genetics, engineering, and drug discovery, to collaborate towards a common goal: improving health outcomes for more people. For those interested in learning more, Insitro can be reached through their website at insitro.com.